dc.contributor.author | Guli, Xiati | |
dc.contributor.author | Tokay, Tursonjan | |
dc.contributor.author | Kirschstein, Timo | |
dc.contributor.author | Köhling, Rüdiger | |
dc.date.accessioned | 2016-02-03T04:41:58Z | |
dc.date.available | 2016-02-03T04:41:58Z | |
dc.date.issued | 2015-11-15 | |
dc.identifier.uri | http://nur.nu.edu.kz/handle/123456789/1133 | |
dc.description.abstract | N-Methyl-D-aspartate (NMDA) receptor-dependent long-term potentiation (LTP) can be reversed by low-frequency stimulation (LFS) referred to as depotentiation (DP). We previously found GluN2B upregulated in CA1 neurons from post-status epilepticus (post-SE) tissue associated with an enhanced LTP. Here,we testedwhether LFS-inducedDP is also altered in pathologicalGluN2B upregulation. Although LTP was enhanced in post-SE tissue, LTP was significantly reversed in this tissue, but not in controls. We next tested the effect of the GluN2B subunit-specific blocker Ro 25-6981 (1 𝜇M) on LFS-DP. As expected, LFS had no effect on synaptic strength in the presence of the GluN2B blocker in control tissue. In marked contrast, LFS-DP was also attained in post-SE tissue indicating that GluN2B was obviously not involved in depotentiation. To test for NMDA receptor-dependence, we applied the NMDA receptor antagonist D-AP5 (50 𝜇M) prior to LFS and observed that DPwas abolished in both control and post- SE tissue confirming NMDA receptor involvement. These results indicate that control Schaffer collateral-CA1 synapses cannot be depotentiated after fully established LTP, but LFS was able to reverse LTP significantly in post-SE tissue. However, while LFS-DP clearly requiredNMDA receptor activation, GluN2B-containingNMDA receptors were not involved in this formof depotentiation | ru_RU |
dc.language.iso | en | ru_RU |
dc.publisher | Neural Plasticity | ru_RU |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | * |
dc.subject | N-Methyl-D-aspartate | ru_RU |
dc.subject | Epilepticus | ru_RU |
dc.subject | Epilepticus enhances depotentiation | ru_RU |
dc.subject | Research Subject Categories::MEDICINE | ru_RU |
dc.title | Status epilepticus enhances depotentiation after fully established LTP in an NMDAR-Dependent but GluN2B-independent manner | ru_RU |
dc.type | Article | ru_RU |
The following license files are associated with this item: